(917) 310-3371
Symptom pattern
Review the symptom, timing, severity, affected muscles, dose relationship, resolution after stopping, and response to any rechallenge.
Cholesterol care | New York
Statin intolerance evaluation in NYC and Long Island
A structured review of symptoms and prior treatment that protects cardiovascular care while looking for a tolerable, evidence-based plan.
Start with evaluation, not a product assumption
The care team must confirm clinical fit, current records, monitoring, access, and the correct site before treatment moves forward.
Direct answer
Statin intolerance is not defined by one symptom after one prescription. The National Lipid Association describes partial and complete intolerance and recommends that at least two statins be tried, including one at the lowest approved daily dose, before the definition is met. A clinician should also assess timing, dose, interactions, other causes of symptoms, and the patient's cardiovascular risk.
Current product and service status
This visit focuses on verifying possible statin intolerance and choosing a practical cholesterol plan. Product-specific information provides more detail when a particular medicine becomes relevant.
What the evaluation clarifies
The goal is to understand what happened, reduce avoidable risk, and find a plan the patient can follow.
Adequate prior trials
Document which statins and doses were tried. The NLA definition expects at least two statins, including one at the lowest approved daily dose.
Other contributors
Review thyroid disease, vitamin or metabolic issues when clinically indicated, strenuous activity, alcohol, interacting medicines, and other causes of muscle symptoms.
Partial and complete intolerance
The distinction matters because many patients can tolerate some statin exposure even if a prior regimen was not tolerable.
Partial intolerance
A patient may tolerate a lower dose, a different statin, or a different schedule, but not enough to reach the treatment goal alone.
Complete intolerance
A patient cannot tolerate an adequate trial of statin therapy after careful assessment. This is less common and still needs documentation.
No automatic substitution
A nonstatin medicine is chosen from the patient's risk, LDL goal, evidence, preferences, safety, and coverage, not from a symptom label alone.
Possible next steps
The clinician and patient should make a shared decision based on the verified history.
Adjust the statin plan
Options may include a different statin, dose, or schedule when appropriate.
Add or use nonstatin treatment
A clinician may discuss oral or injectable nonstatin options when the expected benefit and label fit the patient.
Coordinate higher-risk care
Very high LDL, familial hypercholesterolemia, established cardiovascular disease, or persistent uncertainty may require specialist coordination.
How the evaluation moves forward
The sequence protects safety and keeps a product request from bypassing diagnosis, records, monitoring, access, or referral needs.
Bring the record
Bring recent lipid results, a current medication and supplement list, prior reactions, relevant diagnoses, and family history when available.
Review risk and prior treatment
The clinician reviews the reason for treatment, prior response, safety considerations, adherence barriers, and the role of lifestyle support.
Choose the next step
The plan may include repeat or additional testing, a medication change, teaching, prior-authorization work, specialist coordination, or continued monitoring.
Confirm follow-up
The care team confirms how results and symptoms will be reviewed. Product supply or administration is arranged only after operational capability is verified.
Evaluation locations across New York
Choose a nearby Nao Medical clinic as a starting point for evaluation or care coordination.
Capability boundary: these location cards do not establish that a medicine, device, laboratory test, injection, or specialty workflow is available at every site. Confirm the exact service before travel.
Bronx
174th Street
932 E 174th St, Bronx, NY 10460
A place to begin evaluation and care coordination near West Farms, Crotona Park East, and nearby Bronx neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
A place to begin evaluation and care coordination near Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Bronx
Bartow Mall
2063A Bartow Ave, Bronx, NY 10475
A place to begin evaluation and care coordination near Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Brooklyn
Crown Heights
341 Eastern Pkwy, Brooklyn, NY 11216
A place to begin evaluation and care coordination near Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Long Island
Hicksville
232 W Old Country Rd, Hicksville, NY 11801
A place to begin evaluation and care coordination near Hicksville, Plainview, Bethpage, and nearby Nassau County communities. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Jackson Heights
80-10 Northern Blvd, Jackson Heights, NY 11372
A place to begin evaluation and care coordination near Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Jamaica
90-18 Sutphin Blvd, Jamaica, NY 11435
A place to begin evaluation and care coordination near Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Long Island City
30-07 36th Ave, Astoria, NY 11106
A place to begin evaluation and care coordination near Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Long Island
Mineola
135 Mineola Blvd, Mineola, NY 11501
A place to begin evaluation and care coordination near Mineola, Garden City, Westbury, and nearby Nassau County communities. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Manhattan
StuyTown
259 1st Ave, New York, NY 10003
A place to begin evaluation and care coordination near StuyTown, the East Village, Gramercy, and nearby Manhattan neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Brooklyn
Williamsburg
308 Graham Ave, Brooklyn, NY 11211
A place to begin evaluation and care coordination near Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Related care and next steps
Compare focused options, prepare for an evaluation, and connect medication questions with broader care.
Heart health and cholesterol care
Explore broader cardiovascular prevention and cholesterol care at Nao Medical.
Advanced lipid testing
Use additional measurements only when they can improve a risk or treatment decision.
Familial hypercholesterolemia evaluation
Review inherited risk when LDL levels or family history raise concern.
Leqvio evaluation
Learn about a clinician-administered nonstatin option without assuming candidacy.
Repatha evaluation
Review a self-injected PCSK9 medicine when a product-specific evaluation is warranted.
Frequently asked questions
Answers reflect current official sources and Nao Medical's limited evaluation and coordination scope.
The National Lipid Association describes an adverse effect linked to statin treatment that improves with dose reduction or stopping and results in partial or complete inability to tolerate treatment. At least two statins should be tried, including one at the lowest approved daily dose.
No. Timing, dose, activity, other medicines, thyroid or metabolic issues, and other conditions can matter. A clinician should assess the pattern rather than assume the cause.
Partial intolerance means a person can tolerate some statin therapy, but not the regimen needed to reach the treatment goal by itself.
Do not stop or change a prescribed medicine without instructions from the prescribing clinician unless urgent care is needed for a serious reaction.
No. The next step depends on verified intolerance, cardiovascular risk, LDL goal, prior treatment, safety, preference, and coverage.
Bring the names, doses, dates, symptoms, laboratory results, and outcomes for prior statin trials, plus the current medication and supplement list.
For some patients, a tolerable lower dose or alternate regimen can contribute meaningful LDL lowering and may be combined with another treatment. The clinician should individualize the plan.
Official sources
These sources support product identity, approval, current labeling, availability, and clinical boundaries. They do not prove Nao Medical site capability or health-plan coverage.
NLA scientific statement on statin intolerance
Current definition, requirement for at least two statin trials, partial versus complete intolerance, and reversible contributors.
Open official source2026 guideline on the management of dyslipidemia
Current risk assessment, LDL-lowering treatment, Lp(a), ApoB, and monitoring guidance.
Open official sourceTop things to know: 2026 dyslipidemia guideline
Patient-selection principles and the roles of Lp(a), ApoB, and nonstatin therapies.
Open official sourceSource and label check completed August 1, 2026. Named clinical and operations review is still pending.
Connect the evaluation to specific treatment pathways
Diagnosis and long-term care stay anchored in a full condition evaluation. The focused medication, testing, and service information below helps patients compare next steps without replacing that evaluation.
Leqvio injections
Review whether an injectable cholesterol-lowering pathway may fit after a complete intolerance assessment.
Repatha and Praluent
Compare non-statin options without assuming that every muscle symptom is caused by a statin.
Lerochol information
Review separate market-status and eligibility information for this emerging treatment.
Health information notice
General information only. The information here is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.
Content was updated August 2, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.